A research team from Northwest University, China, has developed a breakthrough nano-composite hydrogel system to address the ...

Herbal drugs (HDs) or herbal medicines have been applied for a very long time as natural remedies for preventing and curing diseases and for improving human health. HDs are currently gaining ...

Gayle Nicholas Scott, Pharm.D., FASCP, BCPS, CGP, is a freelance medical writer and Assistant Professor, Department of Physiological Sciences, Eastern Virginia ...

Am J Health Syst Pharm. 2002;59 (4) Dong Quai Dong quai (Angelica sinesis), a botanical long used in traditional Chinese medicine, is a popular dietary supplement used to treat menopausal symptoms ...

As previously reported at the annual meeting of the American Academy of Allergy, Asthma & Immunology and published in The Lancet in 2023, garadacimab reduced investigator-confirmed HAE attacks by ...

Gilead Sciences drug lenacapavir, brand name Yeztugo, is now approved for HIV pre-exposure prophylaxis. The twice injectable medication is hoped to improve uptake and adherence to PrEP.

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

The twice-yearly injection, known as lenacapavir, offers near-perfect protection against infection across broad populations and geographies, two clinical trials showed. It’s a promising development, ...

Uncertain access The FDA's decision makes lenacapavir available today in the U.S., which sees about 31,000 of the 1.3 million new HIV infections each year worldwide.

FDA Greenlights Twice-A-Year HIV Prevention Drug By Antonio Pequeño IV, Forbes Staff. Pequeño is a breaking news reporter who covers tech and more.

A pharmacist holds a vial of lenacapavir, the injectable drug that prevents HIV infection. On June 18, the FDA approved the drug for use in the U.S. A drug with the potential to drastically curb the ...